The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia

Por Crisan, AM, Coriu, D, Arion, C, Colita, A, Jardan, C
Publicado no J Med Life (2015)

The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression – an overlapping myeloproliferative disorder or two distinct diseases? - case rep...

Por Ursuleac, I, Colita, AC, Adam, T, Jardan, C, Ilea, A, Coriu, D
Publicado em 2013

Cytokine Gene Polymorphisms support diagnostic monitoring of Romanian Multiple Myeloma patients

Por Banu, C, Moise, A, Arion, CV, Coriu, D, T̆nase, A, Constantinescu, I
Publicado em 2011

The simultaneous occurrence of multiple myeloma and JAK2 positive myeloproliferative neoplasms - Report on two cases

Por Badelita, S, Dobrea, C, Colita, A, Dogaru, M, Dragomir, M, Jardan, C, Coriu, D
Publicado no J Med Life (2015)

Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience

Por Coriu, L, Ungureanu, R, Talmaci, R, Uscatescu, V, Cirstoiu, M, Coriu, D, Copaciu, E
Publicado no J Med Life (2014)

Mucormycosis during Imatinib treatment: case report

Por Crisan, AM, Ghiaur, A, Stancioaca, MC, Bardas, A, Ghita, C, Manea, CM, Ionescu, B, Coriu, D
Publicado no J Med Life (2015)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Por Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Publicado no Leukemia (2016)